Value of a new therapeutic agent, diosmine, in proctology
Peeters, J.P.
Bruxelles Medical 53(10): 591-594
1973
ISSN/ISBN: 0068-3027 PMID: 4761153 Document Number: 63911
Document emailed within 1 workday
Related Documents
Mot, J.C. 1976: New therapeutic contribution in proctology: esberiven Medecine and Chirurgie Digestives 5(7): 375-377Van Gysel, J.P.; Veroft, R. 1973: Clinical study of Diosmine (4,601 SE) in phlebological practice in cases of venous insufficiency Phlebologie 26(2): 263-272
Singh, R. 2002: The importance of exercise as a therapeutic agent Malaysian Journal of Medical Sciences: Mjms 9(2): 7-16
Pokrovskiĭ, A.V.; Sapelkin, S.V. 2005: Derivatives of semi-synthetic diosmine in the treatment of patients with chronic venous insufficiency. the results of a prospective study--using phlebodia 600 Angiologiia i Sosudistaia Khirurgiia 11(4): 73-79
Bouffioux, C.; de Leval, J. 1980: Estracyt, new therapeutic agent for cancer of the prostate Revue Medicale de Liege 35(24): 865-870
Heynen, U. 1971: Pimafucin--a polyvalent vaginal therapeutic agent Zeitschrift für Allgemeinmedizin 47(15): 829-830
Chatani, Y. 2005: Minodronic acid hydrate as a new therapeutic agent for osteoporosis Clinical Calcium 15(1): 9-14
Normand, J. 1982: The history of a therapeutic agent: digitalis yesterday and today Annales de Cardiologie et d'Angeiologie 31(2): 89-95
Takeuchi, Y. 2011: Development of hPTHrP (1-36) as an anabolic therapeutic agent for osteoporosis Clinical Calcium 21(1): 28-32
Muniz, C.E.; Ogburn, B.R.; Ampbell, D.R. 1971: Lithium as a therapeutic agent in the treatment of manicdepressive illness Southern Medical Journal 64(2): 177-179
Starks, G.C. 1985: Diagnostic and therapeutic applications of a betamimetic agent in infertility Missouri Medicine 82(1): 21-23
Lipecka, K. 1989: Therapeutic use of superoxide dismutase as an anti-inflammatory agent Polski Tygodnik Lekarski 44(14): 339-340
Gayral, L.F.; Oules, J.J.; Escande, M.M.; Goldberger, E.G. 1978: Therapeutic trial of antidepressive agent 19560-RP metapramine L'Encephale 4(4): 365-370
Kuhlwein, A.; Beykirch, W. 1980: B-carotene as the therapeutic agent for erythropoetic protoporphyria, not the last resort Zeitschrift für Hautkrankheiten 55(12): 817-823
Jezequel, J.; Becuwe, B.; Daniel, C.; Geraudel, O. 1979: Therapeutic trial of a new topical anti-inflammatory agent Journal Francais d'Oto-Rhino-Laryngologie; Audiophonologie Chirurgie Maxillo-Faciale 28(1): 65
Ronger, S.; Viallard, A.M.; Meunier-Mure, F.; Chouvet, B.; Balme, B.; Thomas, L. 2003: Oral calcitriol: a new therapeutic agent in cutaneous lichen sclerosis Journal of Drugs in Dermatology: Jdd 2(1): 23-28
Polosa, P.; Mughini, L. 1978: Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus La Clinica Terapeutica 84(2): 135-140
Breton, J.C.; Bouteille, B.; Sonan, T. 1988: DFMO: an alternative therapeutic agent for human African trypanosomiasis Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 81(3 Part 2): 571-577
Walter, K.; Aschoff, J.C. 1996: Physostigmine. from the God's judgment bean to modern antidote and therapeutic agent Medizinische Monatsschrift für Pharmazeuten 19(9): 252-260
Shturkalev, I.; Katsulov, A. 1970: Results of clinical trials of ovostat as a contraceptive and therapeutic agent Akusherstvo i Ginekologiia 9(5): 383-387